Neothetics (NEOT) Phase 2 Proof of Concept Trial for LIPO-202 Initiated for Double Chin
Tweet Send to a Friend
Neothetics, Inc. (NASDAQ: NEOT) today announced the initiation of the Phase 2 proof of concept trial, LIPO-202-CL-31, for LIPO-202 for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
